The independent prediction of membranous SFRP4 expression in the 5 year mortality of gynaecological cancer patients has a factor of 1.8, which means that the chance of dying earlier of cancer is 80% higher if SFRP4 membrane staining is absent in their tumors at the time of diagnosis. The gene discussed is SFRP4; the disease is cancer.